Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takahide Taguchi

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Auris, Nasus, Larynx|March 6, 2007
Antitumor effects of Nafamostat mesilate on head and neck squamous cell carcinomaYukiko Yamashita, Yukari Ishiguro, Daisuke Sano, et al.
International Journal of Clinical Oncology|April 20, 2007
Decrease of creatinine clearance rate with aging in patients with head and neck cancer in JapanGoshi Nishimura, Mamoru Tsukuda, Choichi Horiuchi, et al.
Cancer Chemotherapy and Pharmacology|May 8, 2016
Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinomaGoshi Nishimura, Takahide Taguchi, Masahiro Takahashi, et al.
International Journal of Clinical Oncology|June 29, 2004
Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neckMamoru Tsukuda, Yasukazu Mikami, Yuji Tanigaki, et al.
Auris, Nasus, Larynx|September 11, 2007
Early assessment of clinical response to concurrent chemoradiotherapy in head and neck carcinoma using fluoro-2-deoxy-d-glucose positron emission tomographyChoichi Horiuchi, Takahide Taguchi, Takafumi Yoshida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2006
[Change of creatinine clearance rate in accordance with aging in Japanese patients with head and neck cancer]Goshi Nishimura, Choichi Horiuchi, Takafumi Yoshida, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 12, 2005
Four cases of simultaneous triple primary cancers of the hypopharynx, esophagus, and stomachYoichi Ikeda, Mamoru Tsukuda, Junichi Ishitoya, et al.
Japanese Journal of Clinical Oncology|October 1, 2014
Phase II study of concurrent chemoradiotherapy with S-1 in patients with stage II (T2N0M0) squamous cell carcinoma of the Pharynx or LarynxTakahide Taguchi, Masahiro Takahashi, Goshi Nishimura, et al.
Japanese Journal of Clinical Oncology|April 2, 2014
Concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neckMasanori Komatsu, Osamu Shiono, Takahide Taguchi, et al.
Anticancer Research|April 1, 2009
Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservationGoshi Nishimura, Mamoru Tsukuda, Yasukazu Mikami, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Auris, Nasus, Larynx|March 6, 2007
Antitumor effects of Nafamostat mesilate on head and neck squamous cell carcinomaYukiko Yamashita, Yukari Ishiguro, Daisuke Sano, et al.
International Journal of Clinical Oncology|April 20, 2007
Decrease of creatinine clearance rate with aging in patients with head and neck cancer in JapanGoshi Nishimura, Mamoru Tsukuda, Choichi Horiuchi, et al.
Cancer Chemotherapy and Pharmacology|May 8, 2016
Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinomaGoshi Nishimura, Takahide Taguchi, Masahiro Takahashi, et al.
International Journal of Clinical Oncology|June 29, 2004
Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neckMamoru Tsukuda, Yasukazu Mikami, Yuji Tanigaki, et al.
Auris, Nasus, Larynx|September 11, 2007
Early assessment of clinical response to concurrent chemoradiotherapy in head and neck carcinoma using fluoro-2-deoxy-d-glucose positron emission tomographyChoichi Horiuchi, Takahide Taguchi, Takafumi Yoshida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2006
[Change of creatinine clearance rate in accordance with aging in Japanese patients with head and neck cancer]Goshi Nishimura, Choichi Horiuchi, Takafumi Yoshida, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 12, 2005
Four cases of simultaneous triple primary cancers of the hypopharynx, esophagus, and stomachYoichi Ikeda, Mamoru Tsukuda, Junichi Ishitoya, et al.
Japanese Journal of Clinical Oncology|October 1, 2014
Phase II study of concurrent chemoradiotherapy with S-1 in patients with stage II (T2N0M0) squamous cell carcinoma of the Pharynx or LarynxTakahide Taguchi, Masahiro Takahashi, Goshi Nishimura, et al.
Japanese Journal of Clinical Oncology|April 2, 2014
Concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neckMasanori Komatsu, Osamu Shiono, Takahide Taguchi, et al.
Anticancer Research|April 1, 2009
Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservationGoshi Nishimura, Mamoru Tsukuda, Yasukazu Mikami, et al.
Pageof 7